Dear Colleagues,

As the Neurogenetic and Neurometabolic Diseases Working Group of the Turkish Neurological Society, we are delighted to sincerely invite you to the 3rd Neurogenetic and Neurometabolic Diseases Congress, which we will hold in Istanbul from April 09–12, 2026.

This year, our congress aims to address current developments in the diagnosis, follow-up, and treatment of neurogenetic and neurometabolic diseases from a holistic perspective, with the contributions of national and international experts. The rapidly expanding body of neurogenetic knowledge has brought with it the hope of accurate diagnosis, early intervention, and even treatability for many of our patients today. Our most important goal is to evaluate this scientific transformation together and to create a common vision for the future.

On the opening day of our congress, we will hold the 12th School of Rare Diseases with the participation of all stakeholders in the field, from relevant associations to academia. In this special program, we will discuss rare diseases from pathophysiology to treatment options; and we will address strategies for increasing awareness, strengthening coordination, and accessing new treatments together with all components of the healthcare system.

In the scientific program of our congress, genetic and metabolic-based diseases located within all sub-disciplines of neurology—particularly neuromuscular diseases, movement disorders, dementia, stroke, neuroimmunology, epilepsy, and neurodevelopmental diseases—will be addressed within a comprehensive and up-to-date framework. The selection of the correct genetic test, evaluation of the phenotype-genotype relationship, advanced diagnostic methods, new treatment approaches, and the strengthening of multidisciplinary patient management are the core components of our program. For this reason, we have further strengthened our scientific program with the contributions of experts in the fields of medical genetics, pediatric neurology, and pediatric and adult metabolism.

With the “Myogenetics in the Region” session, which we will organize for the first time this year, we aim to establish a sustainable cooperation network with experts working in the field of hereditary muscle diseases in our region and to increase joint scientific production.

Let us cultivate science together in the spring of Istanbul, and let us grow hope for our precious patients. We would be honored to see you among us at a congress that is academically strong and socially enjoyable.

We sincerely look forward to your participation and extend our respectful regards.

On Behalf of the Turkish Neurological Society
Neurogenetic and Neurometabolic Diseases Working Group
Prof. Dr. Hacer Durmuş Tekçe